Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 14 | $22,707,098 |
| Sells | 62 | $11,838,280 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 20:43 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 19 Nov 2024 | Sale | 10,329 | 16.81 | 173,630 | D |
| 19 Nov 2024 20:41 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 19 Nov 2024 | Sale | 4,073 | 16.81 | 68,467 | D |
| 19 Nov 2024 20:40 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 19 Nov 2024 | Sale | 10,259 | 16.81 | 172,454 | D |
| 20 Aug 2024 18:46 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 19 Aug 2024 | Sale | 9,733 | 15.28 | 148,720 | D |
| 20 Aug 2024 18:43 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 19 Aug 2024 | Sale | 9,534 | 15.28 | 145,680 | D |
| 20 Aug 2024 18:40 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 19 Aug 2024 | Sale | 31,747 | 15.28 | 485,094 | D |
| 11 Jun 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 10 Jun 2024 | Sale | 975 | 14.79 | 14,420 | D |
| 03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 02 May 2024 | Sale | 3,503 | 16.94 | 59,341 | D |
| 03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 02 May 2024 | Sale | 3,477 | 16.94 | 58,900 | D |
| 03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 02 May 2024 | Sale | 1,326 | 16.94 | 22,462 | D |
| 03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 02 May 2024 | Sale | 11,427 | 16.94 | 193,573 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Apr 2024 | Sale | 17,716 | 17.87 | 316,585 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Apr 2024 | Sale | 8,858 | 17.87 | 158,292 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 08 Apr 2024 | Sale | 2,568 | 17.87 | 45,890 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 08 Apr 2024 | Sale | 762 | 17.87 | 13,617 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 08 Apr 2024 | Sale | 1,028 | 17.87 | 18,370 | D |
| 09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 08 Apr 2024 | Sale | 2,716 | 17.87 | 48,535 | D |
| 27 Mar 2024 20:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 27 Mar 2024 | Sale | 5,140 | 17.9 | 92,006 | D |
| 27 Mar 2024 19:58 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 27 Mar 2024 | Sale | 17,714 | 17.9 | 317,081 | D |
| 27 Mar 2024 19:57 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 5,434 | 17.9 | 97,269 | D |
| 27 Feb 2024 18:13 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 26 Feb 2024 | Sale | 772 | 24.67 | 19,045 | D |
| 27 Feb 2024 18:10 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 26 Feb 2024 | Sale | 624 | 24.67 | 15,394 | D |
| 27 Feb 2024 18:07 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 26 Feb 2024 | Sale | 474 | 24.67 | 11,694 | D |
| 27 Feb 2024 18:02 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 26 Feb 2024 | Sale | 5,577 | 24.67 | 137,585 | D |
| 09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Jan 2024 | Sale | 3,732 | 29.96 | 111,811 | D |
| 09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 08 Jan 2024 | Sale | 731 | 29.96 | 21,901 | D |
| 09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 08 Jan 2024 | Sale | 590 | 29.96 | 17,676 | D |
| 15 Dec 2023 19:37 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 15 Dec 2023 | Sale | 2,000 | 28.3 | 56,600 | D |
| 21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 20 Nov 2023 | Sale | 4,960 | 22.64 | 112,294 | D |
| 21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 20 Nov 2023 | Sale | 5,108 | 22.64 | 115,645 | D |
| 21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 20 Nov 2023 | Sale | 1,985 | 22.64 | 44,940 | D |
| 06 Oct 2023 22:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 06 Oct 2023 | Sale | 16,369 | 21.96 | 359,463 | D |
| 06 Oct 2023 21:59 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 06 Oct 2023 | Sale | 51,563 | 21.96 | 1,132,323 | D |
| 19 Sep 2023 18:31 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 15 Sep 2023 | Sale | 2,000 | 25.88 | 51,760 | D |
| 23 Aug 2023 19:31 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 21 Aug 2023 | Sale | 10,000 | 28.997 | 289,970 | D |
| 18 Jul 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 14 Jul 2023 | Sale | 100,000 | 30.0435 | 3,004,350 | D |
| 13 Jul 2023 20:27 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 12 Jul 2023 | Sale | 55,104 | 25.0517 | 1,380,449 | D |
| 13 Jul 2023 20:27 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 11 Jul 2023 | Sale | 16,498 | 25 | 412,450 | D |
| 16 Jun 2023 16:38 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 15 Jun 2023 | Sale | 2,000 | 24.15 | 48,300 | D |
| 14 Jun 2023 17:14 | ACAD | ACADIA PHARMACEUTICALS INC | BREGE LAURA | Director | 12 Jun 2023 | Sale | 4,500 | 24.868 | 111,906 | D |
| 12 Jun 2023 20:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 08 Jun 2023 | Sale | 974 | 25.02 | 24,369 | D |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 259,109 | 25.65 | 6,646,146 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 24,113 | 25.65 | 618,498 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 28,878 | 25.5138 | 736,788 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 2,688 | 25.5138 | 68,581 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 218,171 | 25.2723 | 5,513,683 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 20,304 | 25.2723 | 513,129 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 74,582 | 25.54 | 1,904,824 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 6,941 | 25.54 | 177,273 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 116,672 | 25.3302 | 2,955,325 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 10,858 | 25.3302 | 275,035 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 40,632 | 24.8 | 1,007,674 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 3,781 | 24.8 | 93,769 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 82,148 | 24.4604 | 2,009,373 | I |
| 24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 7,645 | 24.4604 | 187,000 | I |
| 19 May 2023 18:54 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 17 May 2023 | Sale | 5,947 | 22.5 | 133,808 | D |
| 19 May 2023 18:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 17 May 2023 | Sale | 15,310 | 22.5 | 344,475 | D |
| 19 May 2023 18:43 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 17 May 2023 | Sale | 14,869 | 22.5 | 334,552 | D |
| 02 May 2023 19:06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 01 May 2023 | Sale | 917 | 21.18 | 19,422 | D |
| 02 May 2023 19:04 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 01 May 2023 | Sale | 548 | 21.18 | 11,607 | D |
| 02 May 2023 19:02 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 01 May 2023 | Sale | 7,806 | 21.18 | 165,331 | D |
| 11 Apr 2023 21:15 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 10 Apr 2023 | Sale | 523 | 18.14 | 9,487 | D |
| 07 Apr 2023 20:44 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 06 Apr 2023 | Sale | 1,751 | 18.16 | 31,798 | D |
| 07 Apr 2023 20:41 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 06 Apr 2023 | Sale | 701 | 18.16 | 12,730 | D |
| 07 Apr 2023 20:37 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 06 Apr 2023 | Sale | 1,916 | 18.16 | 34,795 | D |
| 07 Apr 2023 20:34 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 06 Apr 2023 | Sale | 8,582 | 18.16 | 155,849 | D |
| 07 Apr 2023 20:32 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 06 Apr 2023 | Sale | 1,456 | 18.16 | 26,441 | D |
| 27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 24 Feb 2023 | Sale | 350 | 18.78 | 6,573 | D |
| 27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 24 Feb 2023 | Sale | 577 | 18.78 | 10,836 | D |
| 27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 24 Feb 2023 | Sale | 3,851 | 18.78 | 72,322 | D |
| 27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 24 Feb 2023 | Sale | 803 | 18.78 | 15,080 | D |
| 27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 24 Feb 2023 | Sale | 461 | 18.78 | 8,658 | D |
| 17 Jan 2023 17:17 | ACAD | ACADIA PHARMACEUTICALS INC | BREGE LAURA | Director | 12 Jan 2023 | Sale | 12,500 | 18.25 | 228,125 | D |
| 10 Jan 2023 20:38 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 09 Jan 2023 | Sale | 3,904 | 17.1303 | 66,877 | D |
| 10 Jan 2023 20:30 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 09 Jan 2023 | Sale | 532 | 17.1303 | 9,113 | D |
| 10 Jan 2023 20:20 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 09 Jan 2023 | Sale | 589 | 17.1303 | 10,090 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)